CCG 63802
Discontinued Product
Chemical Name: (2E)-2-(1,3-Benzothiazol-2-yl)-3-[9-methyl-2-(3-methylphenoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]acrylonitrile
Purity: ≥99%
Biological Activity
CCG 63802 is a reversible inhibitor of regulator of G-protein signaling (RGS) proteins. Selective amongst RGS proteins, with greatest potency at RGS4. Inhibits GTPase accelerating protein activity of RGS4 and blocks its interaction with Gαo. Retains activity under reducing conditions.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins.
Blazer et al.
Mol.Pharmacol., 2010;78:524
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for CCG 63802
The citations listed below are publications that use Tocris products. Selected citations for CCG 63802 include:
1 Citation: Showing 1 - 1
-
A new model of nerve injury in the rat reveals a role of Regulator of G protein Signaling 4 in tactile hypersensitivity.
Authors: Taccola Et al.
Experimental Neurology 2016;286:1
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for CCG 63802
There are currently no reviews for this product. Be the first to review CCG 63802 and earn rewards!
Have you used CCG 63802?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
